Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSCARBIDOPA\FOSLEVODOPA vs FREMANEZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSCARBIDOPA\FOSLEVODOPA vs FREMANEZUMAB: Safety Overview

Metric FOSCARBIDOPA\FOSLEVODOPA FREMANEZUMAB
Total FAERS Reports 3,161 224
Deaths Reported 431 2
Death Rate 13.6% 0.9%
Hospitalizations 1,747 39
Average Patient Age 70.4 yrs 47.1 yrs
% Female Patients 42.2% 88.8%
Manufacturer N/A Teva Pharmaceuticals USA, Inc.
Route N/A SUBCUTANEOUS